DEA schedule
Is lamivudine a controlled substance?
Federal schedule for lamivudine from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
No. Lamivudine is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and lamivudine is not on the DEA controlled substances list.
Run it in Rivvi
Which 2027 plans near you dropped or restricted lamivudine?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 29 prescription listings from 15 labelers, none with a DEA schedule |
| DEA controlled substances list | lamivudine is not on the list |
Lamivudine NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 49702-205 | EPIVIR | solution | 10 mg/mL | ViiV Healthcare Company | None |
| 49702-203 | EPIVIR | tablet, film coated | 150 mg/1 | ViiV Healthcare Company | None |
| 49702-204 | EPIVIR | tablet, film coated | 300 mg/1 | ViiV Healthcare Company | None |
| 57237-274 | Lamivudine | solution | 10 mg/mL | Rising Pharma Holdings, Inc. | None |
| 62135-706 | lamivudine | solution | 10 mg/mL | Chartwell RX, LLC | None |
| 65862-055 | Lamivudine | solution | 10 mg/mL | Aurobindo Pharma Limited | None |
| 68999-706 | lamivudine | solution | 10 mg/mL | Chartwell Govermental & Specialty RX, LLC. | None |
| 50742-623 | Lamivudine | tablet | 150 mg/1 | Ingenus Pharmaceuticals, LLC | None |
| 50742-624 | Lamivudine | tablet | 300 mg/1 | Ingenus Pharmaceuticals, LLC | None |
| 31722-001 | lamivudine | tablet, film coated | 100 mg/1 | Camber Pharmaceuticals, Inc. | None |
| 31722-752 | Lamivudine | tablet, film coated | 100 mg/1 | Camber Pharmaceuticals, Inc. | None |
| 51407-866 | Lamivudine | tablet, film coated | 100 mg/1 | Golden State Medical Supply, Inc. | None |
| 60505-3250 | Lamivudine | tablet, film coated | 100 mg/1 | Apotex Corp. | None |
| 0904-6583 | LAMIVUDINE | tablet, film coated | 150 mg/1 | Major Pharmaceuticals | None |
| 31722-753 | Lamivudine | tablet, film coated | 150 mg/1 | Camber Pharmaceuticals, Inc. | None |
| 33342-001 | Lamivudine | tablet, film coated | 150 mg/1 | Macleods Pharmaceuticals Limited | None |
| 60429-353 | LAMIVUDINE | tablet, film coated | 150 mg/1 | Golden State Medical Supply, Inc. | None |
| 60505-3251 | LAMIVUDINE | tablet, film coated | 150 mg/1 | Apotex Corp. | None |
| 60687-720 | Lamivudine | tablet, film coated | 150 mg/1 | American Health Packaging | None |
| 64380-710 | Lamivudine | tablet, film coated | 150 mg/1 | Strides Pharma Science Limited | None |
| 65862-025 | Lamivudine | tablet, film coated | 150 mg/1 | Aurobindo Pharma Limited | None |
| 67046-1459 | Lamivudine | tablet, film coated | 150 mg/1 | Coupler LLC | None |
| 68180-602 | Lamivudine | tablet, film coated | 150 mg/1 | Lupin Pharmaceuticals, Inc. | None |
| 31722-754 | Lamivudine | tablet, film coated | 300 mg/1 | Camber Pharmaceuticals, Inc. | None |
| 33342-002 | Lamivudine | tablet, film coated | 300 mg/1 | Macleods Pharmaceuticals Limited | None |
| 60429-354 | LAMIVUDINE | tablet, film coated | 300 mg/1 | Golden State Medical Supply, Inc. | None |
| 60505-3252 | LAMIVUDINE | tablet, film coated | 300 mg/1 | Apotex Corp. | None |
| 64380-711 | Lamivudine | tablet, film coated | 300 mg/1 | Strides Pharma Science Limited | None |
| 65862-026 | Lamivudine | tablet, film coated | 300 mg/1 | Aurobindo Pharma Limited | None |
Questions
Is lamivudine a controlled substance?
No. Lamivudine is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and lamivudine is not on the DEA controlled substances list.
Is lamivudine a narcotic?
No. Lamivudine is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor and Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.
More on Lamivudine
- What is Lamivudine used for?FDA label uses
- Generic for EpivirFDA Orange Book
- Generic for Epivir-hbvFDA Orange Book
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitors listFDA drug class
- Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitors listFDA drug class
- NDC 49702-203Lamivudine NDC record
- NDC 49702-204Lamivudine NDC record
- NDC 49702-205Lamivudine NDC record